Global Biologics Drug Discovery Market According to Goldstein Research, global biologics drug discovery market is expected to reach USD 140.9 billion by 2024 from an estimated market size of USD 56.6 billion in 2016, growing at a CAGR of 12.0% over the forecast period 2016-2024. The high presence of genetic disorders, diabetes, nervous system disorders and cardiovascular diseases and advancement in the field of genetics, structural biology and biotechnology tend to drive the growth of the market. Global biologics drug discovery market segmentation has been done on the basis of technology, end user and geography. Geographically, the global biologics drug discovery industry is dominated by North America with a market share of 38.0% in 2016, owing to high investments in the healthcare and pharmaceutical industry. Download Exclusive Sample Request @ https://www.goldsteinresearch.com/request-sample/global-biologics-drug-discovery-market-outlook-2024-global-opportunity-and-demand-a...